Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Janos M, Rethelyi"'
Publikováno v:
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. 18(4)
Over the past decade we witnessed the birth of a new scientific area that lies at the borders of developmental biology, stem cell biology, basic and clinical neuroscience. In vitro disease modeling refers to the approach that exploits the capacity of
Autor:
Janos M, Rethelyi
Publikováno v:
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. 18(4)
Autor:
Judit, Benkovits, Szilvia, Magyarosi, Attila J, Pulay, Zoltan, Makkos, Aniko, Egerhazi, Nora, Balogh, Peter, Almos, Istvan, Liko, Hungarian, Schizobank Consortium, Gyorgy, Nemeth, Judit Maria, Molnar, Laszlo, Nagy, Janos M, Rethelyi
Publikováno v:
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. 18(4)
Schizophrenia is a chronic, debilitating psychiatric disorder characterized by heterogeneous clinical symptoms. Although the pathogenesis of this disorder is poorly understood, several lines of evidence support the role of both common and rare geneti
Publikováno v:
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. 18(4)
Anti-NMDAR (N-methyl-D-aspartic acid receptor) encephalitis, first described in 2007, is a rare, autoimmune limbic encephalitis. In half of the cases anti-NMDAR antibodies are paraneoplastic manifestations of an underlying tumor (mostly ovarian terat
Autor:
Izabella, Klein, Katalin, Szocs, Katalin, Vincze, Judit, Benkovits, Szilvia, Somogyi, Levente, Herman, Janos M, Rethelyi
Publikováno v:
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. 18(4)
Schizophrenia is a severe debilitating psychiatric disorder, with a typical onset in adolescence or early adulthood. This condition is characterized by heterogeneous symptoms (hallucinations, delusions, disorganized behaviour, affective flattening, a